Elane Fishilevich Email & Phone Number | RNA interference (RNAi) therapies build on our knowledge of human genetics to treat diseases and improve patients’ lives. I am proud to be a part of an RNAi company whose approach is built on body’s natural mechanism to target and treat rare genetic disorders and beyond. Genomics and other high throughput technologies have now come of age, enabling rapid development of RNAi targets from ideas to the clinic. The success of RNAi is a great example of the continuous growth of precision medicine.

Elane Fishilevich

RNA interference (RNAi) therapies build on our knowledge of human genetics to treat diseases and imp...
31 Madison Avenue#3, Cambridge, United States

*50 free lookup(s) per month.

Elane Fishilevich’s Email efishilevich@unl.edu

Elane Fishilevich’s Phone Numbers

Get ELANE’s Phone Number (For Free)

Social Media

Elane Fishilevich’s Location 31 Madison Avenue#3, Cambridge, United States

Elane Fishilevich’s Current Industry Alnylam Pharmaceuticals

Find accurate emails & phone numbers for over 700M professionals.

Director at Almylam Pharmaceuticals

2023-06-01 00:00:00 - Present

Adjunct Associate Professor

2018-04-01 00:00:00 - 2023-06-01 00:00:00

Research Scientist in Discovery R&D

2016-04-01 00:00:00 - 2018-03-01 00:00:00

Research Assistant Professor, Department of Developmental Biology

2011-05-01 00:00:00 - 2013-04-01 00:00:00

Visiting Research Scientist, Department of Computational and Systems Biology

2010-07-01 00:00:00 - 2011-05-01 00:00:00

Postdoctoral Fellow

2006-05-01 00:00:00 - 2010-06-01 00:00:00

Research Assistant

1999-07-01 00:00:00 - 2000-08-01 00:00:00

No Skills Available

No Languages Available

Elane Fishilevich is a RNA interference (RNAi) therapies build on our knowledge of human genetics to treat diseases and improve patients’ lives. I am proud to be a part of an RNAi company whose approach is built on body’s natural mechanism to target and treat rare genetic disorders and beyond. Genomics and other high throughput technologies have now come of age, enabling rapid development of RNAi targets from ideas to the clinic. The success of RNAi is a great example of the continuous growth of precision medicine.

Elane Fishilevich has prior
experience in the following industries:
University Of Nebraska Lincoln | Dow Agrosciences | University Of Pittsburgh | University Of Pittsburgh School Of Medicine | Carnegie Mellon University | The Rockefeller University

Elane Fishilevich has the following professional experience:
Alnylam Pharmaceuticals | University Of Nebraska Lincoln | Dow Agrosciences | University Of Pittsburgh | University Of Pittsburgh School Of Medicine | Carnegie Mellon University | The Rockefeller University